These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 29936382

  • 1. Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: The depletion of intracellular GSH contents arouses chemosensitizing effects.
    Ji X, Tang Q, Pang P, Wu J, Kirk TB, Xu J, Ma D, Xue W.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():293-302. PubMed ID: 29936382
    [Abstract] [Full Text] [Related]

  • 2. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
    Gao YE, Bai S, Shi X, Hou M, Ma X, Zhang T, Xiao B, Xue P, Kang Y, Xu Z.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():488-496. PubMed ID: 29960949
    [Abstract] [Full Text] [Related]

  • 3. A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy.
    Fu D, Ni Z, Wu K, Cheng P, Ji X, Li G, Shang X.
    Drug Deliv; 2021 Dec 01; 28(1):195-205. PubMed ID: 33438472
    [Abstract] [Full Text] [Related]

  • 4. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
    Lan JS, Qin YH, Liu L, Zeng RF, Yang Y, Wang K, Ding Y, Zhang T, Ho RJY.
    Int J Nanomedicine; 2021 Dec 01; 16():1775-1787. PubMed ID: 33692622
    [Abstract] [Full Text] [Related]

  • 5. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
    Bai S, Gao YE, Ma X, Shi X, Hou M, Xue P, Kang Y, Xu Z.
    Carbohydr Polym; 2018 Feb 15; 182():235-244. PubMed ID: 29279120
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
    Yang G, Yang T, Zhang W, Lu M, Ma X, Xiang G.
    J Agric Food Chem; 2014 Mar 12; 62(10):2207-15. PubMed ID: 24528163
    [Abstract] [Full Text] [Related]

  • 7. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
    Jin H, Pi J, Yang F, Jiang J, Wang X, Bai H, Shao M, Huang L, Zhu H, Yang P, Li L, Li T, Cai J, Chen ZW.
    Sci Rep; 2016 Jul 29; 6():30782. PubMed ID: 27469490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The chemical and biological potential of C ring modified triterpenoids.
    Siewert B, Wiemann J, Köwitsch A, Csuk R.
    Eur J Med Chem; 2014 Jan 24; 72():84-101. PubMed ID: 24361521
    [Abstract] [Full Text] [Related]

  • 11. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C, Li H, Shi Y, Wang G, Liu L, Zhao L, Su R.
    Int J Pharm; 2014 Oct 20; 474(1-2):202-11. PubMed ID: 25149123
    [Abstract] [Full Text] [Related]

  • 12. Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro.
    Shan JZ, Xuan YY, Ruan SQ, Sun M.
    Chin J Integr Med; 2011 Aug 20; 17(8):607-11. PubMed ID: 21826595
    [Abstract] [Full Text] [Related]

  • 13. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation.
    Gao Y, Li Z, Xie X, Wang C, You J, Mo F, Jin B, Chen J, Shao J, Chen H, Jia L.
    Eur J Pharm Sci; 2015 Apr 05; 70():55-63. PubMed ID: 25638419
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer.
    Zong L, Cheng G, Zhao J, Zhuang X, Zheng Z, Liu Z, Song F.
    Molecules; 2022 Feb 14; 27(4):. PubMed ID: 35209071
    [Abstract] [Full Text] [Related]

  • 15. Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.
    Chen H, Gao Y, Wang A, Zhou X, Zheng Y, Zhou J.
    Eur J Med Chem; 2015 Mar 06; 92():648-55. PubMed ID: 25617694
    [Abstract] [Full Text] [Related]

  • 16. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
    Zheng G, Shen Y, Zhao R, Chen F, Zhang Y, Xu A, Shao J.
    J Agric Food Chem; 2017 Aug 16; 65(32):6904-6911. PubMed ID: 28771340
    [Abstract] [Full Text] [Related]

  • 17. Particle size tailoring of ursolic acid nanosuspensions for improved anticancer activity by controlled antisolvent precipitation.
    Wang Y, Song J, Chow SF, Chow AH, Zheng Y.
    Int J Pharm; 2015 Oct 15; 494(1):479-89. PubMed ID: 26302857
    [Abstract] [Full Text] [Related]

  • 18. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
    Li J, Yin T, Wang L, Yin L, Zhou J, Huo M.
    Int J Pharm; 2015 Apr 10; 483(1-2):38-48. PubMed ID: 25655715
    [Abstract] [Full Text] [Related]

  • 19. [Experimental study on MCF-7 cell apoptosis induced by ursolic acid].
    Zhang W, Li Y, Zhang G, Lü J, Ou H.
    Zhong Yao Cai; 2005 Apr 10; 28(4):297-301. PubMed ID: 16104504
    [Abstract] [Full Text] [Related]

  • 20. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
    Zhang RX, Li Y, Tian DD, Liu Y, Nian W, Zou X, Chen QZ, Zhou LY, Deng ZL, He BC.
    Int J Oncol; 2016 Nov 10; 49(5):1973-1982. PubMed ID: 27665868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.